Customer Login

About
Pipeline
Products
- Zimeta^™ (dipyrone injection)
Technology
- Veterinary Recombinant Biologics
- Manufacturing Process
Education
- Continuing Education
- KINections
Investors
News
- Press Releases
Contact Us
- Contact Us
- Careers
Menu

Test PI PDF Embed

You are here: Home / Test PI PDF Embed

Mirataz_Full_PI

News

Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal AntibodySeptember 16, 2020 - 8:08 am
Kindred Biosciences to Participate in H.C. Wainwright Global Investment Conference, Cantor Global Healthcare Conference and Lake Street Best Ideas Growth ConferenceSeptember 9, 2020 - 8:06 am
Kindred Biosciences Announces Second Quarter 2020 Financial ResultsAugust 5, 2020 - 4:06 pm

Events

Event: Kindred Biosciences to Present at Cantor Global Healthcare ConferenceSeptember 9, 2020 - 8:12 am
Event: Kindred Biosciences to Present at H.C. Wainwright Global Investment ConferenceSeptember 9, 2020 - 8:09 am
Event: Kindred Biosciences to Present at LD Micro 500August 31, 2020 - 2:59 pm

$4.43

-0.02 (-0.45%)

KIN (Common Stock)
Previous Close	Volume
$4.45	45,959
Intraday High	Intraday Low
$4.49	$4.34
52 Week High	52 Week Low
$11.93	$3.10
Exchange: NASDAQ CM

KindredBio proudly supports
Rabies Free Africa

Contact Us | Careers | Privacy Policy | Website Terms of Use | Forward Looking Statements

© Copyright 2012-2020 | Kindred Biosciences, Inc. | 1555 Bayshore Hwy. Suite 200 Burlingame, CA 94010